UFP Technologies (UFPT) CJS Securities Annual New Ideas For the New Year Conference 2024 summary
Event summary combining transcript, slides, and related documents.
CJS Securities Annual New Ideas For the New Year Conference 2024 summary
10 Jan, 2026Company overview and value proposition
Designs and manufactures med tech devices, sterile packaging, and engineered components, leveraging global material partnerships and in-house engineering expertise.
Serves over 2,000 customers, including 25 of the top 30 med device companies, with a focus on high-margin, high-value projects.
Maintains strong barriers to entry through proprietary equipment, exclusive materials, and deep customer relationships.
Operates 20 manufacturing facilities and 8 R&D centers across 6 countries.
Growth strategy and market focus
Pursues a two-pronged growth strategy: targeted internal growth in high-margin segments and strategic, customer-driven acquisitions.
Continuously analyzes business profitability, focusing on the most lucrative segments and customers while redesigning or exiting less profitable ones.
Recent acquisitions in Ireland, Dominican Republic, Costa Rica, and Asia have expanded geographic reach and access to key materials.
Aims for roughly 50% of growth from internal initiatives and 50% from acquisitions.
Key customer relationships and market dynamics
Maintains a strong, co-invested partnership with Intuitive Surgical, representing over 20% of revenue and supported by long-term agreements.
Dominates the robotic drapes market, with increasing share as competitors exit or reduce focus.
Intuitive Surgical employs a dual-supplier strategy, but the company has become the preferred, lower-cost provider.
Ongoing capacity expansions in the Dominican Republic support rapid customer growth and inventory needs.
Latest events from UFP Technologies
- Q1 2026 revenue up 4.1% to $154.2M, with MedTech growth and margin gains amid ongoing risks.UFPT
Q1 20268 May 2026 - Virtual annual meeting to vote on directors, executive pay, auditor, and highlight governance best practices.UFPT
Proxy filing30 Apr 2026 - Net income up 15.8% and sales up 19.5% to $602.8M, driven by medical market growth.UFPT
Q4 20257 Apr 2026 - Exclusive materials, strategic acquisitions, and strong contracts fuel high-margin growth.UFPT
47th Annual Raymond James Institutional Investor Conference3 Mar 2026 - MedTech-focused manufacturer targets 12–18% revenue growth and 17–20% margins via innovation and acquisitions.UFPT
Investor presentation3 Mar 2026 - Exclusive materials, strategic acquisitions, and medtech focus drive robust growth and margins.UFPT
15th Annual Midwest IDEAS Investor Conference23 Jan 2026 - Exclusive materials, custom processes, and acquisitions fuel rapid Medtech growth and resilience.UFPT
Piper Sandler 37th Annual Healthcare Conference3 Dec 2025 - Annual meeting to vote on directors, executive pay, auditor, and governance practices.UFPT
Proxy Filing2 Dec 2025 - Record Q1 sales up 41% to $148.1M, led by medical growth and strategic expansion.UFPT
Q1 202524 Nov 2025